BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 36427955)

  • 1. Role of the gut microbiome in multiple sclerosis: From etiology to therapeutics.
    Shahi SK; Yadav M; Ghimire S; Mangalam AK
    Int Rev Neurobiol; 2022; 167():185-215. PubMed ID: 36427955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diet-microbiome-immune interplay in multiple sclerosis: Understanding the impact of phytoestrogen metabolizing gut bacteria.
    Lehman PC; Ghimire S; Price JD; Ramer-Tait AE; Mangalam AK
    Eur J Immunol; 2023 Nov; 53(11):e2250236. PubMed ID: 37673213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiome in multiple sclerosis: The players involved and the roles they play.
    Shahi SK; Freedman SN; Mangalam AK
    Gut Microbes; 2017 Nov; 8(6):607-615. PubMed ID: 28696139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Gut Dysbiosis and Potential Approaches to Target the Gut Microbiota in Multiple Sclerosis.
    Ladakis DC; Bhargava P
    CNS Drugs; 2023 Feb; 37(2):117-132. PubMed ID: 36690786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut dysbiosis and multiple sclerosis.
    Noto D; Miyake S
    Clin Immunol; 2022 Feb; 235():108380. PubMed ID: 32169440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The "Gut Feeling": Breaking Down the Role of Gut Microbiome in Multiple Sclerosis.
    Freedman SN; Shahi SK; Mangalam AK
    Neurotherapeutics; 2018 Jan; 15(1):109-125. PubMed ID: 29204955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Gut-Brain Axis in Multiple Sclerosis. Is Its Dysfunction a Pathological Trigger or a Consequence of the Disease?
    Parodi B; Kerlero de Rosbo N
    Front Immunol; 2021; 12():718220. PubMed ID: 34621267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple sclerosis and faecal microbiome transplantation: are you going to eat that?
    Wing AC; Kremenchutzky M
    Benef Microbes; 2019 Feb; 10(1):27-32. PubMed ID: 30525949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting gut microbiota: new therapeutic opportunities in multiple sclerosis.
    Kujawa D; Laczmanski L; Budrewicz S; Pokryszko-Dragan A; Podbielska M
    Gut Microbes; 2023 Dec; 15(2):2274126. PubMed ID: 37979154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A bidirectional association between the gut microbiota and CNS disease in a biphasic murine model of multiple sclerosis.
    Colpitts SL; Kasper EJ; Keever A; Liljenberg C; Kirby T; Magori K; Kasper LH; Ochoa-Repáraz J
    Gut Microbes; 2017 Nov; 8(6):561-573. PubMed ID: 28708466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feeding the gut microbiome: impact on multiple sclerosis.
    Bronzini M; Maglione A; Rosso R; Matta M; Masuzzo F; Rolla S; Clerico M
    Front Immunol; 2023; 14():1176016. PubMed ID: 37304278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Dynamics of the Gut Microbiome in Multiple Sclerosis in Relation to Disease.
    Mowry EM; Glenn JD
    Neurol Clin; 2018 Feb; 36(1):185-196. PubMed ID: 29157399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of the Gut Microbiome in Multiple Sclerosis Risk and Progression: Towards Characterization of the "MS Microbiome".
    Pröbstel AK; Baranzini SE
    Neurotherapeutics; 2018 Jan; 15(1):126-134. PubMed ID: 29147991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Host Genetics and Gut Microbiome: Perspectives for Multiple Sclerosis.
    Maglione A; Zuccalà M; Tosi M; Clerico M; Rolla S
    Genes (Basel); 2021 Jul; 12(8):. PubMed ID: 34440354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the gut to treat multiple sclerosis.
    Ghezzi L; Cantoni C; Pinget GV; Zhou Y; Piccio L
    J Clin Invest; 2021 Jul; 131(13):. PubMed ID: 34196310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of the Gut Microbiome and Immunity in Multiple Sclerosis: Impact of Diet and Immune Therapy.
    Yadav SK; Ito K; Dhib-Jalbut S
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Gut Microbiota in Multiple Sclerosis and Potential Therapeutic Implications.
    Wang X; Liang Z; Wang S; Ma D; Zhu M; Feng J
    Curr Neuropharmacol; 2022; 20(7):1413-1426. PubMed ID: 34191698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple sclerosis: Possibility of a gut environment-induced disease.
    Sato W; Yamamura T
    Neurochem Int; 2019 Nov; 130():104475. PubMed ID: 31152766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple Sclerosis-Associated Gut Microbiome in the Israeli Diverse Populations: Associations with Ethnicity, Gender, Disability Status, Vitamin D Levels, and Mediterranean Diet.
    Nitzan Z; Staun-Ram E; Volkowich A; Miller A
    Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The second brain: The connection between gut microbiota composition and multiple sclerosis.
    Farshbafnadi M; Agah E; Rezaei N
    J Neuroimmunol; 2021 Nov; 360():577700. PubMed ID: 34482269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.